nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM2—oviduct—uterine cancer	0.0155	0.0318	CbGeAlD
L-Glutamine—TGM4—epithelium—uterine cancer	0.00947	0.0194	CbGeAlD
L-Glutamine—Glutathione—GPX3—uterine cancer	0.00797	0.814	CrCbGaD
L-Glutamine—GLUL—oviduct—uterine cancer	0.00678	0.0139	CbGeAlD
L-Glutamine—TGM5—endometrium—uterine cancer	0.00589	0.0121	CbGeAlD
L-Glutamine—TGM5—mammalian vulva—uterine cancer	0.00569	0.0117	CbGeAlD
L-Glutamine—TGM1—uterine cervix—uterine cancer	0.00526	0.0108	CbGeAlD
L-Glutamine—TGM3—uterine cervix—uterine cancer	0.00493	0.0101	CbGeAlD
L-Glutamine—GMPS—myometrium—uterine cancer	0.00467	0.00957	CbGeAlD
L-Glutamine—CTPS1—myometrium—uterine cancer	0.00467	0.00957	CbGeAlD
L-Glutamine—TGM1—mammalian vulva—uterine cancer	0.00461	0.00945	CbGeAlD
L-Glutamine—PFAS—myometrium—uterine cancer	0.00458	0.0094	CbGeAlD
L-Glutamine—GFPT2—myometrium—uterine cancer	0.00458	0.0094	CbGeAlD
L-Glutamine—NADSYN1—uterine cervix—uterine cancer	0.00451	0.00925	CbGeAlD
L-Glutamine—TGM5—vagina—uterine cancer	0.00441	0.00905	CbGeAlD
L-Glutamine—TGM3—mammalian vulva—uterine cancer	0.00432	0.00885	CbGeAlD
L-Glutamine—F13A1—myometrium—uterine cancer	0.00411	0.00843	CbGeAlD
L-Glutamine—TGM1—female reproductive system—uterine cancer	0.00394	0.00809	CbGeAlD
L-Glutamine—CCBL1—decidua—uterine cancer	0.00394	0.00809	CbGeAlD
L-Glutamine—GLUL—exocrine gland—uterine cancer	0.00391	0.00803	CbGeAlD
L-Glutamine—QARS—myometrium—uterine cancer	0.00391	0.00802	CbGeAlD
L-Glutamine—TGM2—epithelium—uterine cancer	0.00389	0.00798	CbGeAlD
L-Glutamine—CCBL1—renal system—uterine cancer	0.00387	0.00794	CbGeAlD
L-Glutamine—GATB—renal system—uterine cancer	0.00387	0.00794	CbGeAlD
L-Glutamine—TGM2—smooth muscle tissue—uterine cancer	0.00375	0.00769	CbGeAlD
L-Glutamine—CCBL1—endometrium—uterine cancer	0.00374	0.00768	CbGeAlD
L-Glutamine—GLS—renal system—uterine cancer	0.00365	0.00748	CbGeAlD
L-Glutamine—CTPS1—uterine cervix—uterine cancer	0.00363	0.00745	CbGeAlD
L-Glutamine—GMPS—uterine cervix—uterine cancer	0.00363	0.00745	CbGeAlD
L-Glutamine—TGM2—renal system—uterine cancer	0.00361	0.0074	CbGeAlD
L-Glutamine—CAD—myometrium—uterine cancer	0.0036	0.00739	CbGeAlD
L-Glutamine—TGM1—female gonad—uterine cancer	0.00359	0.00736	CbGeAlD
L-Glutamine—TGM1—vagina—uterine cancer	0.00357	0.00732	CbGeAlD
L-Glutamine—PFAS—uterine cervix—uterine cancer	0.00357	0.00731	CbGeAlD
L-Glutamine—GFPT2—uterine cervix—uterine cancer	0.00357	0.00731	CbGeAlD
L-Glutamine—CAD—Levonorgestrel—Progesterone—uterine cancer	0.00347	0.36	CbGdCrCtD
L-Glutamine—GFPT2—smooth muscle tissue—uterine cancer	0.00347	0.00711	CbGeAlD
L-Glutamine—CTPS1—decidua—uterine cancer	0.00346	0.0071	CbGeAlD
L-Glutamine—PFAS—decidua—uterine cancer	0.0034	0.00697	CbGeAlD
L-Glutamine—GFPT2—decidua—uterine cancer	0.0034	0.00697	CbGeAlD
L-Glutamine—GMPS—renal system—uterine cancer	0.0034	0.00697	CbGeAlD
L-Glutamine—CTPS1—renal system—uterine cancer	0.0034	0.00697	CbGeAlD
L-Glutamine—NADSYN1—female reproductive system—uterine cancer	0.00338	0.00693	CbGeAlD
L-Glutamine—GLS2—female reproductive system—uterine cancer	0.00338	0.00693	CbGeAlD
L-Glutamine—PPAT—myometrium—uterine cancer	0.00334	0.00686	CbGeAlD
L-Glutamine—TGM3—vagina—uterine cancer	0.00334	0.00686	CbGeAlD
L-Glutamine—GFPT2—renal system—uterine cancer	0.00334	0.00684	CbGeAlD
L-Glutamine—GMPS—endometrium—uterine cancer	0.00328	0.00674	CbGeAlD
L-Glutamine—CTPS1—endometrium—uterine cancer	0.00328	0.00674	CbGeAlD
L-Glutamine—PFAS—endometrium—uterine cancer	0.00323	0.00662	CbGeAlD
L-Glutamine—GFPT2—endometrium—uterine cancer	0.00323	0.00662	CbGeAlD
L-Glutamine—TGM2—uterus—uterine cancer	0.00321	0.00659	CbGeAlD
L-Glutamine—F13A1—uterine cervix—uterine cancer	0.0032	0.00656	CbGeAlD
L-Glutamine—CTPS1—mammalian vulva—uterine cancer	0.00318	0.00652	CbGeAlD
L-Glutamine—GMPS—mammalian vulva—uterine cancer	0.00318	0.00652	CbGeAlD
L-Glutamine—PFAS—Levonorgestrel—Progesterone—uterine cancer	0.00313	0.324	CbGdCrCtD
L-Glutamine—PFAS—mammalian vulva—uterine cancer	0.00312	0.0064	CbGeAlD
L-Glutamine—GFPT2—mammalian vulva—uterine cancer	0.00312	0.0064	CbGeAlD
L-Glutamine—GATB—female reproductive system—uterine cancer	0.0031	0.00636	CbGeAlD
L-Glutamine—SLC1A5—myometrium—uterine cancer	0.0031	0.00635	CbGeAlD
L-Glutamine—NADSYN1—female gonad—uterine cancer	0.00308	0.00631	CbGeAlD
L-Glutamine—GLS2—female gonad—uterine cancer	0.00308	0.00631	CbGeAlD
L-Glutamine—GLS2—vagina—uterine cancer	0.00306	0.00627	CbGeAlD
L-Glutamine—NADSYN1—vagina—uterine cancer	0.00306	0.00627	CbGeAlD
L-Glutamine—F13A1—decidua—uterine cancer	0.00305	0.00625	CbGeAlD
L-Glutamine—QARS—uterine cervix—uterine cancer	0.00304	0.00624	CbGeAlD
L-Glutamine—CTPS1—Levonorgestrel—Progesterone—uterine cancer	0.00304	0.315	CbGdCrCtD
L-Glutamine—CTPS1—uterus—uterine cancer	0.00303	0.00621	CbGeAlD
L-Glutamine—F13A1—renal system—uterine cancer	0.00299	0.00614	CbGeAlD
L-Glutamine—GFPT2—uterus—uterine cancer	0.00297	0.0061	CbGeAlD
L-Glutamine—QARS—smooth muscle tissue—uterine cancer	0.00296	0.00606	CbGeAlD
L-Glutamine—GLS—female reproductive system—uterine cancer	0.00292	0.00599	CbGeAlD
L-Glutamine—QARS—decidua—uterine cancer	0.0029	0.00594	CbGeAlD
L-Glutamine—F13A1—endometrium—uterine cancer	0.00289	0.00594	CbGeAlD
L-Glutamine—TGM2—female reproductive system—uterine cancer	0.00289	0.00593	CbGeAlD
L-Glutamine—QARS—renal system—uterine cancer	0.00285	0.00584	CbGeAlD
L-Glutamine—GATB—female gonad—uterine cancer	0.00282	0.00579	CbGeAlD
L-Glutamine—CCBL1—female gonad—uterine cancer	0.00282	0.00579	CbGeAlD
L-Glutamine—CAD—uterine cervix—uterine cancer	0.00281	0.00575	CbGeAlD
L-Glutamine—GATB—vagina—uterine cancer	0.00281	0.00575	CbGeAlD
L-Glutamine—CCBL1—vagina—uterine cancer	0.00281	0.00575	CbGeAlD
L-Glutamine—F13A1—mammalian vulva—uterine cancer	0.0028	0.00574	CbGeAlD
L-Glutamine—QARS—endometrium—uterine cancer	0.00275	0.00564	CbGeAlD
L-Glutamine—GMPS—female reproductive system—uterine cancer	0.00272	0.00558	CbGeAlD
L-Glutamine—CTPS1—female reproductive system—uterine cancer	0.00272	0.00558	CbGeAlD
L-Glutamine—CAD—decidua—uterine cancer	0.00267	0.00548	CbGeAlD
L-Glutamine—GFPT2—female reproductive system—uterine cancer	0.00267	0.00548	CbGeAlD
L-Glutamine—PFAS—female reproductive system—uterine cancer	0.00267	0.00548	CbGeAlD
L-Glutamine—F13A1—uterus—uterine cancer	0.00267	0.00547	CbGeAlD
L-Glutamine—QARS—mammalian vulva—uterine cancer	0.00266	0.00546	CbGeAlD
L-Glutamine—GLS—female gonad—uterine cancer	0.00266	0.00545	CbGeAlD
L-Glutamine—ASNS—myometrium—uterine cancer	0.00266	0.00545	CbGeAlD
L-Glutamine—GLS—vagina—uterine cancer	0.00264	0.00542	CbGeAlD
L-Glutamine—TGM2—female gonad—uterine cancer	0.00263	0.00539	CbGeAlD
L-Glutamine—PPAT—uterine cervix—uterine cancer	0.0026	0.00534	CbGeAlD
L-Glutamine—Abdominal distension—Progesterone—uterine cancer	0.00255	0.00841	CcSEcCtD
L-Glutamine—CAD—endometrium—uterine cancer	0.00254	0.0052	CbGeAlD
L-Glutamine—QARS—uterus—uterine cancer	0.00253	0.0052	CbGeAlD
L-Glutamine—Rigors—Etoposide—uterine cancer	0.00253	0.00835	CcSEcCtD
L-Glutamine—GMPS—female gonad—uterine cancer	0.00248	0.00508	CbGeAlD
L-Glutamine—CTPS1—female gonad—uterine cancer	0.00248	0.00508	CbGeAlD
L-Glutamine—Sepsis—Dactinomycin—uterine cancer	0.00247	0.00817	CcSEcCtD
L-Glutamine—Proctalgia—Epirubicin—uterine cancer	0.00247	0.00815	CcSEcCtD
L-Glutamine—Sweating increased—Progesterone—uterine cancer	0.00246	0.00814	CcSEcCtD
L-Glutamine—CTPS1—vagina—uterine cancer	0.00246	0.00505	CbGeAlD
L-Glutamine—GMPS—vagina—uterine cancer	0.00246	0.00505	CbGeAlD
L-Glutamine—CAD—mammalian vulva—uterine cancer	0.00245	0.00503	CbGeAlD
L-Glutamine—GFPT2—female gonad—uterine cancer	0.00243	0.00499	CbGeAlD
L-Glutamine—PFAS—female gonad—uterine cancer	0.00243	0.00499	CbGeAlD
L-Glutamine—SLC1A5—epithelium—uterine cancer	0.00243	0.00498	CbGeAlD
L-Glutamine—GFPT2—vagina—uterine cancer	0.00242	0.00496	CbGeAlD
L-Glutamine—PFAS—vagina—uterine cancer	0.00242	0.00496	CbGeAlD
L-Glutamine—SLC1A5—uterine cervix—uterine cancer	0.00241	0.00494	CbGeAlD
L-Glutamine—F13A1—female reproductive system—uterine cancer	0.0024	0.00492	CbGeAlD
L-Glutamine—PPAT—endometrium—uterine cancer	0.00235	0.00483	CbGeAlD
L-Glutamine—Pain—Carboplatin—uterine cancer	0.00234	0.00774	CcSEcCtD
L-Glutamine—SLC1A5—smooth muscle tissue—uterine cancer	0.00234	0.0048	CbGeAlD
L-Glutamine—CAD—uterus—uterine cancer	0.00234	0.0048	CbGeAlD
L-Glutamine—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00231	0.00762	CcSEcCtD
L-Glutamine—TGM1—lymph node—uterine cancer	0.00231	0.00473	CbGeAlD
L-Glutamine—SLC1A5—decidua—uterine cancer	0.0023	0.00471	CbGeAlD
L-Glutamine—Proctalgia—Doxorubicin—uterine cancer	0.00228	0.00754	CcSEcCtD
L-Glutamine—QARS—female reproductive system—uterine cancer	0.00228	0.00467	CbGeAlD
L-Glutamine—PPAT—mammalian vulva—uterine cancer	0.00228	0.00467	CbGeAlD
L-Glutamine—SLC1A5—renal system—uterine cancer	0.00225	0.00462	CbGeAlD
L-Glutamine—Depression—Progesterone—uterine cancer	0.00225	0.00743	CcSEcCtD
L-Glutamine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.00738	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Progesterone—uterine cancer	0.00221	0.00731	CcSEcCtD
L-Glutamine—F13A1—female gonad—uterine cancer	0.00218	0.00447	CbGeAlD
L-Glutamine—SLC1A5—endometrium—uterine cancer	0.00218	0.00447	CbGeAlD
L-Glutamine—GLUL—myometrium—uterine cancer	0.00217	0.00445	CbGeAlD
L-Glutamine—F13A1—vagina—uterine cancer	0.00217	0.00445	CbGeAlD
L-Glutamine—Body temperature increased—Carboplatin—uterine cancer	0.00217	0.00715	CcSEcCtD
L-Glutamine—Anorectal discomfort—Epirubicin—uterine cancer	0.00212	0.00699	CcSEcCtD
L-Glutamine—SLC1A5—mammalian vulva—uterine cancer	0.00211	0.00432	CbGeAlD
L-Glutamine—CAD—female reproductive system—uterine cancer	0.0021	0.00431	CbGeAlD
L-Glutamine—QARS—female gonad—uterine cancer	0.00207	0.00425	CbGeAlD
L-Glutamine—ASNS—uterine cervix—uterine cancer	0.00207	0.00424	CbGeAlD
L-Glutamine—SLC7A8—decidua—uterine cancer	0.00207	0.00424	CbGeAlD
L-Glutamine—QARS—vagina—uterine cancer	0.00206	0.00423	CbGeAlD
L-Glutamine—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00673	CcSEcCtD
L-Glutamine—Rhinitis—Progesterone—uterine cancer	0.00203	0.00671	CcSEcCtD
L-Glutamine—SLC7A8—renal system—uterine cancer	0.00203	0.00416	CbGeAlD
L-Glutamine—Pharyngitis—Progesterone—uterine cancer	0.00201	0.00664	CcSEcCtD
L-Glutamine—ASNS—smooth muscle tissue—uterine cancer	0.00201	0.00412	CbGeAlD
L-Glutamine—SLC1A5—uterus—uterine cancer	0.00201	0.00412	CbGeAlD
L-Glutamine—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.002	0.00662	CcSEcCtD
L-Glutamine—Urinary tract disorder—Progesterone—uterine cancer	0.002	0.00661	CcSEcCtD
L-Glutamine—Gastric ulcer—Epirubicin—uterine cancer	0.00199	0.00657	CcSEcCtD
L-Glutamine—Urethral disorder—Progesterone—uterine cancer	0.00199	0.00656	CcSEcCtD
L-Glutamine—GLS2—lymph node—uterine cancer	0.00198	0.00406	CbGeAlD
L-Glutamine—NADSYN1—lymph node—uterine cancer	0.00198	0.00406	CbGeAlD
L-Glutamine—Candida infection—Etoposide—uterine cancer	0.00197	0.00651	CcSEcCtD
L-Glutamine—ASNS—decidua—uterine cancer	0.00197	0.00404	CbGeAlD
L-Glutamine—Anorectal discomfort—Doxorubicin—uterine cancer	0.00196	0.00647	CcSEcCtD
L-Glutamine—PPAT—female reproductive system—uterine cancer	0.00195	0.004	CbGeAlD
L-Glutamine—Enlargement abdomen—Epirubicin—uterine cancer	0.00192	0.00635	CcSEcCtD
L-Glutamine—CAD—female gonad—uterine cancer	0.00191	0.00392	CbGeAlD
L-Glutamine—CAD—vagina—uterine cancer	0.0019	0.0039	CbGeAlD
L-Glutamine—ASNS—endometrium—uterine cancer	0.00187	0.00383	CbGeAlD
L-Glutamine—Gastric ulcer—Doxorubicin—uterine cancer	0.00184	0.00608	CcSEcCtD
L-Glutamine—Angiopathy—Progesterone—uterine cancer	0.00184	0.00607	CcSEcCtD
L-Glutamine—L-Methionine—MTHFR—uterine cancer	0.00182	0.186	CrCbGaD
L-Glutamine—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00602	CcSEcCtD
L-Glutamine—GATB—lymph node—uterine cancer	0.00181	0.00372	CbGeAlD
L-Glutamine—CCBL1—lymph node—uterine cancer	0.00181	0.00372	CbGeAlD
L-Glutamine—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00599	CcSEcCtD
L-Glutamine—ASNS—mammalian vulva—uterine cancer	0.00181	0.00371	CbGeAlD
L-Glutamine—SLC1A5—female reproductive system—uterine cancer	0.0018	0.0037	CbGeAlD
L-Glutamine—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00594	CcSEcCtD
L-Glutamine—Sepsis—Etoposide—uterine cancer	0.00179	0.00591	CcSEcCtD
L-Glutamine—Nail disorder—Epirubicin—uterine cancer	0.00178	0.00589	CcSEcCtD
L-Glutamine—Enlargement abdomen—Doxorubicin—uterine cancer	0.00178	0.00588	CcSEcCtD
L-Glutamine—Mental disorder—Progesterone—uterine cancer	0.00177	0.00586	CcSEcCtD
L-Glutamine—PPAT—female gonad—uterine cancer	0.00177	0.00364	CbGeAlD
L-Glutamine—PPAT—vagina—uterine cancer	0.00176	0.00362	CbGeAlD
L-Glutamine—Malnutrition—Progesterone—uterine cancer	0.00176	0.00582	CcSEcCtD
L-Glutamine—Flatulence—Progesterone—uterine cancer	0.00174	0.00574	CcSEcCtD
L-Glutamine—ASNS—uterus—uterine cancer	0.00172	0.00353	CbGeAlD
L-Glutamine—GLS—lymph node—uterine cancer	0.00171	0.00351	CbGeAlD
L-Glutamine—Back pain—Progesterone—uterine cancer	0.00171	0.00563	CcSEcCtD
L-Glutamine—GLUL—epithelium—uterine cancer	0.0017	0.00349	CbGeAlD
L-Glutamine—GLUL—uterine cervix—uterine cancer	0.00169	0.00346	CbGeAlD
L-Glutamine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.0055	CcSEcCtD
L-Glutamine—Nail disorder—Doxorubicin—uterine cancer	0.00165	0.00545	CcSEcCtD
L-Glutamine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00544	CcSEcCtD
L-Glutamine—SLC1A5—female gonad—uterine cancer	0.00164	0.00337	CbGeAlD
L-Glutamine—GLUL—smooth muscle tissue—uterine cancer	0.00164	0.00336	CbGeAlD
L-Glutamine—Ill-defined disorder—Progesterone—uterine cancer	0.00164	0.0054	CcSEcCtD
L-Glutamine—SLC1A5—vagina—uterine cancer	0.00163	0.00335	CbGeAlD
L-Glutamine—SLC7A8—female reproductive system—uterine cancer	0.00163	0.00333	CbGeAlD
L-Glutamine—GLUL—decidua—uterine cancer	0.00161	0.0033	CbGeAlD
L-Glutamine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00531	CcSEcCtD
L-Glutamine—Laryngitis—Epirubicin—uterine cancer	0.0016	0.0053	CcSEcCtD
L-Glutamine—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00528	CcSEcCtD
L-Glutamine—CTPS1—lymph node—uterine cancer	0.00159	0.00326	CbGeAlD
L-Glutamine—GMPS—lymph node—uterine cancer	0.00159	0.00326	CbGeAlD
L-Glutamine—Malaise—Progesterone—uterine cancer	0.00159	0.00525	CcSEcCtD
L-Glutamine—GLUL—renal system—uterine cancer	0.00158	0.00324	CbGeAlD
L-Glutamine—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.0052	CcSEcCtD
L-Glutamine—PFAS—lymph node—uterine cancer	0.00156	0.00321	CbGeAlD
L-Glutamine—GFPT2—lymph node—uterine cancer	0.00156	0.00321	CbGeAlD
L-Glutamine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.0051	CcSEcCtD
L-Glutamine—GLUL—endometrium—uterine cancer	0.00153	0.00313	CbGeAlD
L-Glutamine—Myalgia—Progesterone—uterine cancer	0.0015	0.00496	CcSEcCtD
L-Glutamine—Chest pain—Progesterone—uterine cancer	0.0015	0.00496	CcSEcCtD
L-Glutamine—Arthralgia—Progesterone—uterine cancer	0.0015	0.00496	CcSEcCtD
L-Glutamine—Fungal infection—Epirubicin—uterine cancer	0.0015	0.00495	CcSEcCtD
L-Glutamine—Laryngitis—Doxorubicin—uterine cancer	0.00148	0.0049	CcSEcCtD
L-Glutamine—Discomfort—Progesterone—uterine cancer	0.00148	0.0049	CcSEcCtD
L-Glutamine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0049	CcSEcCtD
L-Glutamine—SLC7A8—female gonad—uterine cancer	0.00148	0.00303	CbGeAlD
L-Glutamine—GLUL—mammalian vulva—uterine cancer	0.00148	0.00303	CbGeAlD
L-Glutamine—SLC7A8—vagina—uterine cancer	0.00147	0.00301	CbGeAlD
L-Glutamine—Dry mouth—Progesterone—uterine cancer	0.00147	0.00485	CcSEcCtD
L-Glutamine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00476	CcSEcCtD
L-Glutamine—Oedema—Progesterone—uterine cancer	0.00144	0.00475	CcSEcCtD
L-Glutamine—Infection—Progesterone—uterine cancer	0.00143	0.00472	CcSEcCtD
L-Glutamine—Pharyngitis—Dactinomycin—uterine cancer	0.00142	0.00469	CcSEcCtD
L-Glutamine—Rigors—Epirubicin—uterine cancer	0.00142	0.00468	CcSEcCtD
L-Glutamine—Injection site pain—Epirubicin—uterine cancer	0.00142	0.00468	CcSEcCtD
L-Glutamine—ASNS—female gonad—uterine cancer	0.00141	0.00289	CbGeAlD
L-Glutamine—GLUL—uterus—uterine cancer	0.00141	0.00289	CbGeAlD
L-Glutamine—F13A1—lymph node—uterine cancer	0.0014	0.00288	CbGeAlD
L-Glutamine—ASNS—vagina—uterine cancer	0.0014	0.00287	CbGeAlD
L-Glutamine—Hyperhidrosis—Progesterone—uterine cancer	0.00139	0.00459	CcSEcCtD
L-Glutamine—Fungal infection—Doxorubicin—uterine cancer	0.00139	0.00458	CcSEcCtD
L-Glutamine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00449	CcSEcCtD
L-Glutamine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00449	CcSEcCtD
L-Glutamine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00449	CcSEcCtD
L-Glutamine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00444	CcSEcCtD
L-Glutamine—QARS—lymph node—uterine cancer	0.00133	0.00273	CbGeAlD
L-Glutamine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00439	CcSEcCtD
L-Glutamine—Breast pain—Epirubicin—uterine cancer	0.00133	0.00438	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00131	0.00433	CcSEcCtD
L-Glutamine—Rigors—Doxorubicin—uterine cancer	0.00131	0.00433	CcSEcCtD
L-Glutamine—Injection site pain—Doxorubicin—uterine cancer	0.00131	0.00433	CcSEcCtD
L-Glutamine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00431	CcSEcCtD
L-Glutamine—Insomnia—Progesterone—uterine cancer	0.0013	0.0043	CcSEcCtD
L-Glutamine—SLC16A10—epithelium—uterine cancer	0.0013	0.00266	CbGeAlD
L-Glutamine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00428	CcSEcCtD
L-Glutamine—Chills—Dactinomycin—uterine cancer	0.00128	0.00424	CcSEcCtD
L-Glutamine—Viral infection—Epirubicin—uterine cancer	0.00128	0.00423	CcSEcCtD
L-Glutamine—GLUL—female reproductive system—uterine cancer	0.00126	0.00259	CbGeAlD
L-Glutamine—Sweating increased—Etoposide—uterine cancer	0.00126	0.00416	CcSEcCtD
L-Glutamine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00416	CcSEcCtD
L-Glutamine—Fatigue—Progesterone—uterine cancer	0.00124	0.0041	CcSEcCtD
L-Glutamine—Pain—Progesterone—uterine cancer	0.00123	0.00406	CcSEcCtD
L-Glutamine—Constipation—Progesterone—uterine cancer	0.00123	0.00406	CcSEcCtD
L-Glutamine—CAD—lymph node—uterine cancer	0.00123	0.00252	CbGeAlD
L-Glutamine—Breast pain—Doxorubicin—uterine cancer	0.00123	0.00405	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00392	CcSEcCtD
L-Glutamine—Feeling abnormal—Progesterone—uterine cancer	0.00119	0.00392	CcSEcCtD
L-Glutamine—Viral infection—Doxorubicin—uterine cancer	0.00118	0.00391	CcSEcCtD
L-Glutamine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.0039	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Progesterone—uterine cancer	0.00118	0.00389	CcSEcCtD
L-Glutamine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00116	0.00382	CcSEcCtD
L-Glutamine—GLUL—female gonad—uterine cancer	0.00115	0.00236	CbGeAlD
L-Glutamine—Injection site reaction—Epirubicin—uterine cancer	0.00115	0.0038	CcSEcCtD
L-Glutamine—GLUL—vagina—uterine cancer	0.00114	0.00235	CbGeAlD
L-Glutamine—PPAT—lymph node—uterine cancer	0.00114	0.00234	CbGeAlD
L-Glutamine—Body temperature increased—Progesterone—uterine cancer	0.00114	0.00376	CcSEcCtD
L-Glutamine—Abdominal pain—Progesterone—uterine cancer	0.00114	0.00376	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Etoposide—uterine cancer	0.00113	0.00374	CcSEcCtD
L-Glutamine—SLC16A10—mammalian vulva—uterine cancer	0.00113	0.00231	CbGeAlD
L-Glutamine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00371	CcSEcCtD
L-Glutamine—Malaise—Dactinomycin—uterine cancer	0.00112	0.00371	CcSEcCtD
L-Glutamine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00368	CcSEcCtD
L-Glutamine—Candida infection—Epirubicin—uterine cancer	0.0011	0.00365	CcSEcCtD
L-Glutamine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00355	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00352	CcSEcCtD
L-Glutamine—Injection site reaction—Doxorubicin—uterine cancer	0.00106	0.00351	CcSEcCtD
L-Glutamine—Myalgia—Dactinomycin—uterine cancer	0.00106	0.0035	CcSEcCtD
L-Glutamine—Hypersensitivity—Progesterone—uterine cancer	0.00106	0.0035	CcSEcCtD
L-Glutamine—SLC1A5—lymph node—uterine cancer	0.00106	0.00217	CbGeAlD
L-Glutamine—Discomfort—Dactinomycin—uterine cancer	0.00105	0.00346	CcSEcCtD
L-Glutamine—Asthenia—Progesterone—uterine cancer	0.00103	0.00341	CcSEcCtD
L-Glutamine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.0034	CcSEcCtD
L-Glutamine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.0034	CcSEcCtD
L-Glutamine—Urinary tract disorder—Etoposide—uterine cancer	0.00102	0.00338	CcSEcCtD
L-Glutamine—Candida infection—Doxorubicin—uterine cancer	0.00102	0.00337	CcSEcCtD
L-Glutamine—Pruritus—Progesterone—uterine cancer	0.00102	0.00336	CcSEcCtD
L-Glutamine—Oedema—Dactinomycin—uterine cancer	0.00102	0.00336	CcSEcCtD
L-Glutamine—Urethral disorder—Etoposide—uterine cancer	0.00102	0.00335	CcSEcCtD
L-Glutamine—Infection—Dactinomycin—uterine cancer	0.00101	0.00334	CcSEcCtD
L-Glutamine—Sepsis—Epirubicin—uterine cancer	0.001	0.00332	CcSEcCtD
L-Glutamine—SLC16A10—female reproductive system—uterine cancer	0.000964	0.00198	CbGeAlD
L-Glutamine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000961	0.00317	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Epirubicin—uterine cancer	0.00096	0.00317	CcSEcCtD
L-Glutamine—Dizziness—Progesterone—uterine cancer	0.000951	0.00314	CcSEcCtD
L-Glutamine—SLC7A8—lymph node—uterine cancer	0.000951	0.00195	CbGeAlD
L-Glutamine—Angiopathy—Etoposide—uterine cancer	0.00094	0.00311	CcSEcCtD
L-Glutamine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000935	0.00309	CcSEcCtD
L-Glutamine—Chills—Etoposide—uterine cancer	0.00093	0.00307	CcSEcCtD
L-Glutamine—Sepsis—Doxorubicin—uterine cancer	0.000928	0.00307	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000926	0.00306	CcSEcCtD
L-Glutamine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000922	0.00305	CcSEcCtD
L-Glutamine—Vomiting—Progesterone—uterine cancer	0.000915	0.00302	CcSEcCtD
L-Glutamine—Rash—Progesterone—uterine cancer	0.000907	0.003	CcSEcCtD
L-Glutamine—Dermatitis—Progesterone—uterine cancer	0.000906	0.00299	CcSEcCtD
L-Glutamine—ASNS—lymph node—uterine cancer	0.000906	0.00186	CbGeAlD
L-Glutamine—Headache—Progesterone—uterine cancer	0.000901	0.00298	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000889	0.00294	CcSEcCtD
L-Glutamine—Fatigue—Dactinomycin—uterine cancer	0.000877	0.0029	CcSEcCtD
L-Glutamine—Back pain—Etoposide—uterine cancer	0.000872	0.00288	CcSEcCtD
L-Glutamine—SLC16A10—vagina—uterine cancer	0.000872	0.00179	CbGeAlD
L-Glutamine—Pain—Dactinomycin—uterine cancer	0.00087	0.00287	CcSEcCtD
L-Glutamine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000862	0.00285	CcSEcCtD
L-Glutamine—Nausea—Progesterone—uterine cancer	0.000855	0.00282	CcSEcCtD
L-Glutamine—Feeling abnormal—Dactinomycin—uterine cancer	0.000838	0.00277	CcSEcCtD
L-Glutamine—Ill-defined disorder—Etoposide—uterine cancer	0.000837	0.00276	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000832	0.00275	CcSEcCtD
L-Glutamine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000829	0.00274	CcSEcCtD
L-Glutamine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000822	0.00272	CcSEcCtD
L-Glutamine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000821	0.00271	CcSEcCtD
L-Glutamine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000817	0.0027	CcSEcCtD
L-Glutamine—Malaise—Etoposide—uterine cancer	0.000813	0.00269	CcSEcCtD
L-Glutamine—Body temperature increased—Dactinomycin—uterine cancer	0.000804	0.00266	CcSEcCtD
L-Glutamine—Abdominal pain—Dactinomycin—uterine cancer	0.000804	0.00266	CcSEcCtD
L-Glutamine—Dehydration—Epirubicin—uterine cancer	0.000781	0.00258	CcSEcCtD
L-Glutamine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000774	0.00256	CcSEcCtD
L-Glutamine—Chest pain—Etoposide—uterine cancer	0.000768	0.00254	CcSEcCtD
L-Glutamine—Discomfort—Etoposide—uterine cancer	0.000759	0.00251	CcSEcCtD
L-Glutamine—Hypersensitivity—Dactinomycin—uterine cancer	0.000749	0.00248	CcSEcCtD
L-Glutamine—GLUL—lymph node—uterine cancer	0.00074	0.00152	CbGeAlD
L-Glutamine—Infection—Etoposide—uterine cancer	0.000731	0.00242	CcSEcCtD
L-Glutamine—Abdominal distension—Epirubicin—uterine cancer	0.00073	0.00241	CcSEcCtD
L-Glutamine—Asthenia—Dactinomycin—uterine cancer	0.00073	0.00241	CcSEcCtD
L-Glutamine—Dehydration—Doxorubicin—uterine cancer	0.000722	0.00239	CcSEcCtD
L-Glutamine—Hyperhidrosis—Etoposide—uterine cancer	0.000712	0.00235	CcSEcCtD
L-Glutamine—Pancreatitis—Epirubicin—uterine cancer	0.000711	0.00235	CcSEcCtD
L-Glutamine—Abdominal distension—Doxorubicin—uterine cancer	0.000676	0.00223	CcSEcCtD
L-Glutamine—Pancreatitis—Doxorubicin—uterine cancer	0.000658	0.00217	CcSEcCtD
L-Glutamine—Vomiting—Dactinomycin—uterine cancer	0.000647	0.00214	CcSEcCtD
L-Glutamine—Rash—Dactinomycin—uterine cancer	0.000641	0.00212	CcSEcCtD
L-Glutamine—Fatigue—Etoposide—uterine cancer	0.000635	0.0021	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000634	0.00209	CcSEcCtD
L-Glutamine—Pain—Etoposide—uterine cancer	0.000629	0.00208	CcSEcCtD
L-Glutamine—Constipation—Etoposide—uterine cancer	0.000629	0.00208	CcSEcCtD
L-Glutamine—Feeling abnormal—Etoposide—uterine cancer	0.000607	0.002	CcSEcCtD
L-Glutamine—Nausea—Dactinomycin—uterine cancer	0.000604	0.002	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Etoposide—uterine cancer	0.000602	0.00199	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000587	0.00194	CcSEcCtD
L-Glutamine—Rhinitis—Epirubicin—uterine cancer	0.000582	0.00192	CcSEcCtD
L-Glutamine—Abdominal pain—Etoposide—uterine cancer	0.000582	0.00192	CcSEcCtD
L-Glutamine—Body temperature increased—Etoposide—uterine cancer	0.000582	0.00192	CcSEcCtD
L-Glutamine—Pharyngitis—Epirubicin—uterine cancer	0.000576	0.0019	CcSEcCtD
L-Glutamine—Urinary tract disorder—Epirubicin—uterine cancer	0.000573	0.00189	CcSEcCtD
L-Glutamine—Urethral disorder—Epirubicin—uterine cancer	0.000569	0.00188	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—uterine cancer	0.000564	0.00116	CbGeAlD
L-Glutamine—PPAT—Metabolism—NDUFB11—uterine cancer	0.000555	0.00292	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—SRD5A2—uterine cancer	0.000555	0.00292	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—AKR1C1—uterine cancer	0.000546	0.00287	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKR1B1—uterine cancer	0.000545	0.00286	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKR1B1—uterine cancer	0.000545	0.00286	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—STAR—uterine cancer	0.000545	0.00286	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—STAR—uterine cancer	0.000545	0.00286	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—STAR—uterine cancer	0.000545	0.00286	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKR1B1—uterine cancer	0.000545	0.00286	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Etoposide—uterine cancer	0.000542	0.00179	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—uterine cancer	0.000539	0.00178	CcSEcCtD
L-Glutamine—GMPS—Metabolism—POLD1—uterine cancer	0.000535	0.00281	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—POLD1—uterine cancer	0.000535	0.00281	CbGpPWpGaD
L-Glutamine—Pharyngitis—Doxorubicin—uterine cancer	0.000533	0.00176	CcSEcCtD
L-Glutamine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000531	0.00175	CcSEcCtD
L-Glutamine—Asthenia—Etoposide—uterine cancer	0.000528	0.00174	CcSEcCtD
L-Glutamine—Angiopathy—Epirubicin—uterine cancer	0.000527	0.00174	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—uterine cancer	0.000527	0.00174	CcSEcCtD
L-Glutamine—Chills—Epirubicin—uterine cancer	0.000521	0.00172	CcSEcCtD
L-Glutamine—Pruritus—Etoposide—uterine cancer	0.000521	0.00172	CcSEcCtD
L-Glutamine—Mental disorder—Epirubicin—uterine cancer	0.000509	0.00168	CcSEcCtD
L-Glutamine—Malnutrition—Epirubicin—uterine cancer	0.000506	0.00167	CcSEcCtD
L-Glutamine—PFAS—Metabolism—AKR1C1—uterine cancer	0.0005	0.00263	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKR1C1—uterine cancer	0.0005	0.00263	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—RRM2—uterine cancer	0.0005	0.00263	CbGpPWpGaD
L-Glutamine—Flatulence—Epirubicin—uterine cancer	0.000498	0.00165	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—NRAS—uterine cancer	0.000496	0.0026	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—INHBA—uterine cancer	0.000495	0.0026	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—POLD1—uterine cancer	0.000489	0.00257	CbGpPWpGaD
L-Glutamine—Back pain—Epirubicin—uterine cancer	0.000489	0.00162	CcSEcCtD
L-Glutamine—Angiopathy—Doxorubicin—uterine cancer	0.000487	0.00161	CcSEcCtD
L-Glutamine—Dizziness—Etoposide—uterine cancer	0.000487	0.00161	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—DCN—uterine cancer	0.000486	0.00255	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—PGR—uterine cancer	0.000483	0.00254	CbGpPWpGaD
L-Glutamine—Chills—Doxorubicin—uterine cancer	0.000482	0.00159	CcSEcCtD
L-Glutamine—CCBL1—Disease—AKR1C1—uterine cancer	0.000477	0.00251	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—DCN—uterine cancer	0.000473	0.00248	CbGpPWpGaD
L-Glutamine—Mental disorder—Doxorubicin—uterine cancer	0.000471	0.00156	CcSEcCtD
L-Glutamine—Ill-defined disorder—Epirubicin—uterine cancer	0.000469	0.00155	CcSEcCtD
L-Glutamine—Vomiting—Etoposide—uterine cancer	0.000468	0.00155	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—uterine cancer	0.000468	0.00155	CcSEcCtD
L-Glutamine—ASNS—Metabolism of proteins—MME—uterine cancer	0.000465	0.00245	CbGpPWpGaD
L-Glutamine—Rash—Etoposide—uterine cancer	0.000464	0.00153	CcSEcCtD
L-Glutamine—Dermatitis—Etoposide—uterine cancer	0.000464	0.00153	CcSEcCtD
L-Glutamine—Headache—Etoposide—uterine cancer	0.000461	0.00152	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—uterine cancer	0.000461	0.00152	CcSEcCtD
L-Glutamine—QARS—Gene Expression—EZH2—uterine cancer	0.000458	0.00241	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—AKR1C1—uterine cancer	0.000457	0.0024	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CYP11A1—uterine cancer	0.000457	0.0024	CbGpPWpGaD
L-Glutamine—Malaise—Epirubicin—uterine cancer	0.000456	0.00151	CcSEcCtD
L-Glutamine—Back pain—Doxorubicin—uterine cancer	0.000452	0.00149	CcSEcCtD
L-Glutamine—GMPS—Metabolism—RRM2—uterine cancer	0.000446	0.00234	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—RRM2—uterine cancer	0.000446	0.00234	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—NRAS—uterine cancer	0.000443	0.00233	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—STAR—uterine cancer	0.000439	0.00231	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKR1B1—uterine cancer	0.000439	0.00231	CbGpPWpGaD
L-Glutamine—Nausea—Etoposide—uterine cancer	0.000437	0.00144	CcSEcCtD
L-Glutamine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000434	0.00143	CcSEcCtD
L-Glutamine—GLUL—Metabolism—NDUFB11—uterine cancer	0.000433	0.00227	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SRD5A2—uterine cancer	0.000433	0.00227	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SRD5A2—uterine cancer	0.000433	0.00227	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NDUFB11—uterine cancer	0.000433	0.00227	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—DCN—uterine cancer	0.000433	0.00227	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—DCN—uterine cancer	0.000433	0.00227	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—AKR1C3—uterine cancer	0.000432	0.00227	CbGpPWpGaD
L-Glutamine—Arthralgia—Epirubicin—uterine cancer	0.00043	0.00142	CcSEcCtD
L-Glutamine—Chest pain—Epirubicin—uterine cancer	0.00043	0.00142	CcSEcCtD
L-Glutamine—Myalgia—Epirubicin—uterine cancer	0.00043	0.00142	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—POLD1—uterine cancer	0.000427	0.00225	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—POLD1—uterine cancer	0.000427	0.00225	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—POLD1—uterine cancer	0.000427	0.00225	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—KRAS—uterine cancer	0.000426	0.00224	CbGpPWpGaD
L-Glutamine—Discomfort—Epirubicin—uterine cancer	0.000425	0.0014	CcSEcCtD
L-Glutamine—QARS—Gene Expression—ESR2—uterine cancer	0.000425	0.00223	CbGpPWpGaD
L-Glutamine—Malaise—Doxorubicin—uterine cancer	0.000422	0.00139	CcSEcCtD
L-Glutamine—Dry mouth—Epirubicin—uterine cancer	0.000421	0.00139	CcSEcCtD
L-Glutamine—NADSYN1—Disease—AKR1C3—uterine cancer	0.00042	0.00221	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—DCN—uterine cancer	0.000413	0.00217	CbGpPWpGaD
L-Glutamine—Oedema—Epirubicin—uterine cancer	0.000413	0.00136	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—IRF1—uterine cancer	0.000411	0.00216	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.000411	0.00216	CbGpPWpGaD
L-Glutamine—Infection—Epirubicin—uterine cancer	0.00041	0.00135	CcSEcCtD
L-Glutamine—NADSYN1—Disease—HMGA1—uterine cancer	0.00041	0.00215	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—RRM2—uterine cancer	0.000408	0.00214	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CYP11A1—uterine cancer	0.000408	0.00214	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CYP11A1—uterine cancer	0.000408	0.00214	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—STAR—uterine cancer	0.000402	0.00211	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKR1B1—uterine cancer	0.000402	0.00211	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKR1C1—uterine cancer	0.0004	0.0021	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKR1C1—uterine cancer	0.0004	0.0021	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKR1C1—uterine cancer	0.0004	0.0021	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Epirubicin—uterine cancer	0.000399	0.00132	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—uterine cancer	0.000398	0.00132	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—uterine cancer	0.000398	0.00132	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—uterine cancer	0.000398	0.00132	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—DCN—uterine cancer	0.000396	0.00208	CbGpPWpGaD
L-Glutamine—Discomfort—Doxorubicin—uterine cancer	0.000393	0.0013	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—uterine cancer	0.000389	0.00129	CcSEcCtD
L-Glutamine—PFAS—Metabolism—AKR1C3—uterine cancer	0.000385	0.00202	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKR1C3—uterine cancer	0.000385	0.00202	CbGpPWpGaD
L-Glutamine—Oedema—Doxorubicin—uterine cancer	0.000382	0.00126	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—KRAS—uterine cancer	0.000381	0.002	CbGpPWpGaD
L-Glutamine—Infection—Doxorubicin—uterine cancer	0.000379	0.00125	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000376	0.00124	CcSEcCtD
L-Glutamine—NADSYN1—Disease—FBXW7—uterine cancer	0.000375	0.00197	CbGpPWpGaD
L-Glutamine—Insomnia—Epirubicin—uterine cancer	0.000373	0.00123	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—CYP11A1—uterine cancer	0.000373	0.00196	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000369	0.00122	CcSEcCtD
L-Glutamine—CCBL1—Disease—AKR1C3—uterine cancer	0.000368	0.00193	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000367	0.00193	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—HRAS—uterine cancer	0.000363	0.00191	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HMGA1—uterine cancer	0.000358	0.00188	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—RRM2—uterine cancer	0.000356	0.00187	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—RRM2—uterine cancer	0.000356	0.00187	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—RRM2—uterine cancer	0.000356	0.00187	CbGpPWpGaD
L-Glutamine—Fatigue—Epirubicin—uterine cancer	0.000356	0.00118	CcSEcCtD
L-Glutamine—Constipation—Epirubicin—uterine cancer	0.000353	0.00117	CcSEcCtD
L-Glutamine—Pain—Epirubicin—uterine cancer	0.000353	0.00117	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—AKR1C3—uterine cancer	0.000352	0.00185	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—PIK3CA—uterine cancer	0.00035	0.00184	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000348	0.00115	CcSEcCtD
L-Glutamine—GLS—Metabolism—DCN—uterine cancer	0.000346	0.00182	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—DCN—uterine cancer	0.000346	0.00182	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—DCN—uterine cancer	0.000346	0.00182	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—CDKN2B—uterine cancer	0.000346	0.00182	CbGpPWpGaD
L-Glutamine—Insomnia—Doxorubicin—uterine cancer	0.000345	0.00114	CcSEcCtD
L-Glutamine—CAD—Metabolism—POLD1—uterine cancer	0.000345	0.00181	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Epirubicin—uterine cancer	0.00034	0.00112	CcSEcCtD
L-Glutamine—GLS—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000339	0.00178	CbGpPWpGaD
L-Glutamine—GLS2—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000339	0.00178	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000337	0.00111	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—STK11—uterine cancer	0.000337	0.00177	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CYP19A1—uterine cancer	0.000337	0.00177	CbGpPWpGaD
L-Glutamine—Fatigue—Doxorubicin—uterine cancer	0.000329	0.00109	CcSEcCtD
L-Glutamine—CCBL1—Disease—FBXW7—uterine cancer	0.000328	0.00172	CbGpPWpGaD
L-Glutamine—Pain—Doxorubicin—uterine cancer	0.000326	0.00108	CcSEcCtD
L-Glutamine—Constipation—Doxorubicin—uterine cancer	0.000326	0.00108	CcSEcCtD
L-Glutamine—Body temperature increased—Epirubicin—uterine cancer	0.000326	0.00108	CcSEcCtD
L-Glutamine—Abdominal pain—Epirubicin—uterine cancer	0.000326	0.00108	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—CYP11A1—uterine cancer	0.000326	0.00171	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP11A1—uterine cancer	0.000326	0.00171	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CYP11A1—uterine cancer	0.000326	0.00171	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—HRAS—uterine cancer	0.000324	0.0017	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKR1C1—uterine cancer	0.000322	0.00169	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	0.000321	0.00169	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—AKT1—uterine cancer	0.00032	0.00168	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—SMAD3—uterine cancer	0.000316	0.00166	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—POLD1—uterine cancer	0.000315	0.00166	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Doxorubicin—uterine cancer	0.000315	0.00104	CcSEcCtD
L-Glutamine—ASNS—Metabolism—AKR1B1—uterine cancer	0.000313	0.00164	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—STAR—uterine cancer	0.000313	0.00164	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKR1B1—uterine cancer	0.000313	0.00164	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—STAR—uterine cancer	0.000313	0.00164	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000312	0.00103	CcSEcCtD
L-Glutamine—GLS2—Metabolism—AKR1C3—uterine cancer	0.000308	0.00162	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKR1C3—uterine cancer	0.000308	0.00162	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKR1C3—uterine cancer	0.000308	0.00162	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—FBXW7—uterine cancer	0.000306	0.00161	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Epirubicin—uterine cancer	0.000304	0.001	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—uterine cancer	0.000302	0.000997	CcSEcCtD
L-Glutamine—Body temperature increased—Doxorubicin—uterine cancer	0.000302	0.000997	CcSEcCtD
L-Glutamine—GMPS—Metabolism—STK11—uterine cancer	0.0003	0.00158	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—STK11—uterine cancer	0.0003	0.00158	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CYP19A1—uterine cancer	0.0003	0.00158	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CYP19A1—uterine cancer	0.0003	0.00158	CbGpPWpGaD
L-Glutamine—Asthenia—Epirubicin—uterine cancer	0.000296	0.000978	CcSEcCtD
L-Glutamine—PPAT—Metabolism—AKR1C1—uterine cancer	0.000295	0.00155	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN2B—uterine cancer	0.000294	0.00154	CbGpPWpGaD
L-Glutamine—Pruritus—Epirubicin—uterine cancer	0.000292	0.000964	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—CCL2—uterine cancer	0.000291	0.00153	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—RRM2—uterine cancer	0.000287	0.00151	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Doxorubicin—uterine cancer	0.000281	0.000929	CcSEcCtD
L-Glutamine—CAD—Metabolism—DCN—uterine cancer	0.000279	0.00147	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—STK11—uterine cancer	0.000274	0.00144	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—CYP19A1—uterine cancer	0.000274	0.00144	CbGpPWpGaD
L-Glutamine—Asthenia—Doxorubicin—uterine cancer	0.000274	0.000905	CcSEcCtD
L-Glutamine—Dizziness—Epirubicin—uterine cancer	0.000273	0.000901	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—uterine cancer	0.00027	0.000892	CcSEcCtD
L-Glutamine—NADSYN1—Disease—SMAD3—uterine cancer	0.000268	0.00141	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP11A1—uterine cancer	0.000263	0.00138	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—RRM2—uterine cancer	0.000263	0.00138	CbGpPWpGaD
L-Glutamine—Vomiting—Epirubicin—uterine cancer	0.000262	0.000867	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—AKT1—uterine cancer	0.000262	0.00138	CbGpPWpGaD
L-Glutamine—Rash—Epirubicin—uterine cancer	0.00026	0.000859	CcSEcCtD
L-Glutamine—Dermatitis—Epirubicin—uterine cancer	0.00026	0.000859	CcSEcCtD
L-Glutamine—GLS—Neuronal System—HRAS—uterine cancer	0.00026	0.00137	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—HRAS—uterine cancer	0.00026	0.00137	CbGpPWpGaD
L-Glutamine—Headache—Epirubicin—uterine cancer	0.000258	0.000854	CcSEcCtD
L-Glutamine—QARS—Gene Expression—ESR1—uterine cancer	0.000258	0.00135	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN2B—uterine cancer	0.000257	0.00135	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—FGFR2—uterine cancer	0.000256	0.00134	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—DCN—uterine cancer	0.000255	0.00134	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—MTHFR—uterine cancer	0.000253	0.00133	CbGpPWpGaD
L-Glutamine—Dizziness—Doxorubicin—uterine cancer	0.000252	0.000834	CcSEcCtD
L-Glutamine—CAD—Metabolism—AKR1C3—uterine cancer	0.000248	0.0013	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MTHFR—uterine cancer	0.000246	0.00129	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—POLD1—uterine cancer	0.000246	0.00129	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—POLD1—uterine cancer	0.000246	0.00129	CbGpPWpGaD
L-Glutamine—Nausea—Epirubicin—uterine cancer	0.000245	0.00081	CcSEcCtD
L-Glutamine—Vomiting—Doxorubicin—uterine cancer	0.000243	0.000802	CcSEcCtD
L-Glutamine—Rash—Doxorubicin—uterine cancer	0.000241	0.000795	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—uterine cancer	0.00024	0.000794	CcSEcCtD
L-Glutamine—PPAT—Metabolism—CYP11A1—uterine cancer	0.00024	0.00126	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—STK11—uterine cancer	0.00024	0.00126	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—STK11—uterine cancer	0.00024	0.00126	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—STK11—uterine cancer	0.00024	0.00126	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CYP19A1—uterine cancer	0.00024	0.00126	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CYP19A1—uterine cancer	0.00024	0.00126	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP19A1—uterine cancer	0.00024	0.00126	CbGpPWpGaD
L-Glutamine—Headache—Doxorubicin—uterine cancer	0.000239	0.00079	CcSEcCtD
L-Glutamine—CCBL1—Disease—SMAD3—uterine cancer	0.000234	0.00123	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—CXCL8—uterine cancer	0.00023	0.00121	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKR1C1—uterine cancer	0.00023	0.00121	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKR1C1—uterine cancer	0.00023	0.00121	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKR1C3—uterine cancer	0.000227	0.00119	CbGpPWpGaD
L-Glutamine—Nausea—Doxorubicin—uterine cancer	0.000227	0.000749	CcSEcCtD
L-Glutamine—GMPS—Metabolism—MTHFR—uterine cancer	0.000225	0.00118	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—MTHFR—uterine cancer	0.000225	0.00118	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—EP300—uterine cancer	0.000224	0.00117	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—FGFR2—uterine cancer	0.000224	0.00117	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MTHFR—uterine cancer	0.000215	0.00113	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—CTNNB1—uterine cancer	0.000212	0.00112	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—VEGFA—uterine cancer	0.000212	0.00111	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—NRAS—uterine cancer	0.000209	0.0011	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—MTHFR—uterine cancer	0.000206	0.00108	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—RRM2—uterine cancer	0.000205	0.00108	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—RRM2—uterine cancer	0.000205	0.00108	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—DCN—uterine cancer	0.000199	0.00104	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—DCN—uterine cancer	0.000199	0.00104	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000195	0.00102	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP19A1—uterine cancer	0.000193	0.00102	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—STK11—uterine cancer	0.000193	0.00102	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP11A1—uterine cancer	0.000187	0.000984	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP11A1—uterine cancer	0.000187	0.000984	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—MTHFR—uterine cancer	0.00018	0.000947	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—MTHFR—uterine cancer	0.00018	0.000947	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—MTHFR—uterine cancer	0.00018	0.000947	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—KRAS—uterine cancer	0.00018	0.000946	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP19A1—uterine cancer	0.000177	0.000929	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—STK11—uterine cancer	0.000177	0.000929	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKR1C3—uterine cancer	0.000177	0.000929	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKR1C3—uterine cancer	0.000177	0.000929	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PIK3CA—uterine cancer	0.000165	0.000869	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ERBB2—uterine cancer	0.000161	0.000844	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—uterine cancer	0.00016	0.000841	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CCL2—uterine cancer	0.000157	0.000826	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—uterine cancer	0.000153	0.000804	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—uterine cancer	0.000149	0.000784	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1B—uterine cancer	0.000149	0.000782	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—MTHFR—uterine cancer	0.000145	0.000763	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTEN—uterine cancer	0.000141	0.000739	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CTNNB1—uterine cancer	0.000141	0.000738	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ERBB2—uterine cancer	0.00014	0.000738	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—STK11—uterine cancer	0.000138	0.000724	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—STK11—uterine cancer	0.000138	0.000724	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP19A1—uterine cancer	0.000138	0.000724	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP19A1—uterine cancer	0.000138	0.000724	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTEN—uterine cancer	0.000137	0.00072	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—AKT1—uterine cancer	0.000135	0.00071	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—EP300—uterine cancer	0.000134	0.000705	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—MTHFR—uterine cancer	0.000133	0.000698	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EP300—uterine cancer	0.000131	0.000686	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1B—uterine cancer	0.00013	0.000683	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—EP300—uterine cancer	0.000128	0.000675	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTEN—uterine cancer	0.000125	0.000659	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTEN—uterine cancer	0.000125	0.000659	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CXCL8—uterine cancer	0.000124	0.000653	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CTNNB1—uterine cancer	0.000123	0.000645	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NRAS—uterine cancer	0.000122	0.000642	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—uterine cancer	0.000122	0.000639	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NRAS—uterine cancer	0.00012	0.000631	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTEN—uterine cancer	0.00012	0.000629	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—EP300—uterine cancer	0.00012	0.000629	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—EP300—uterine cancer	0.00012	0.000629	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTEN—uterine cancer	0.000115	0.000603	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CTNNB1—uterine cancer	0.000115	0.000602	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EP300—uterine cancer	0.000114	0.0006	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—EP300—uterine cancer	0.000109	0.000575	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NRAS—uterine cancer	0.000107	0.000561	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KRAS—uterine cancer	0.000105	0.000553	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—MTHFR—uterine cancer	0.000103	0.000544	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—MTHFR—uterine cancer	0.000103	0.000544	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—KRAS—uterine cancer	0.000103	0.000543	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTEN—uterine cancer	0.0001	0.000527	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTEN—uterine cancer	0.0001	0.000527	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTEN—uterine cancer	0.0001	0.000527	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CA—uterine cancer	9.93e-05	0.000522	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CA—uterine cancer	9.66e-05	0.000508	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—EP300—uterine cancer	9.56e-05	0.000502	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—EP300—uterine cancer	9.56e-05	0.000502	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—EP300—uterine cancer	9.56e-05	0.000502	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CA—uterine cancer	9.5e-05	0.000499	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—AKT1—uterine cancer	9.29e-05	0.000488	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KRAS—uterine cancer	9.19e-05	0.000483	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—uterine cancer	9.19e-05	0.000483	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—uterine cancer	8.94e-05	0.00047	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CA—uterine cancer	8.85e-05	0.000465	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CA—uterine cancer	8.85e-05	0.000465	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—uterine cancer	8.79e-05	0.000462	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CA—uterine cancer	8.44e-05	0.000444	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—AKT1—uterine cancer	8.11e-05	0.000426	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CA—uterine cancer	8.09e-05	0.000425	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTEN—uterine cancer	8.08e-05	0.000425	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—AKT1—uterine cancer	7.89e-05	0.000415	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—uterine cancer	7.81e-05	0.000411	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—AKT1—uterine cancer	7.76e-05	0.000408	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—EP300—uterine cancer	7.71e-05	0.000405	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTEN—uterine cancer	7.39e-05	0.000388	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—AKT1—uterine cancer	7.23e-05	0.00038	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKT1—uterine cancer	7.23e-05	0.00038	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CA—uterine cancer	7.07e-05	0.000372	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CA—uterine cancer	7.07e-05	0.000372	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CA—uterine cancer	7.07e-05	0.000372	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—EP300—uterine cancer	7.05e-05	0.00037	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—AKT1—uterine cancer	6.9e-05	0.000363	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—AKT1—uterine cancer	6.61e-05	0.000347	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKT1—uterine cancer	5.78e-05	0.000304	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKT1—uterine cancer	5.78e-05	0.000304	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKT1—uterine cancer	5.78e-05	0.000304	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTEN—uterine cancer	5.76e-05	0.000303	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTEN—uterine cancer	5.76e-05	0.000303	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CA—uterine cancer	5.7e-05	0.0003	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—EP300—uterine cancer	5.49e-05	0.000289	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—EP300—uterine cancer	5.49e-05	0.000289	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CA—uterine cancer	5.21e-05	0.000274	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKT1—uterine cancer	4.66e-05	0.000245	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKT1—uterine cancer	4.26e-05	0.000224	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CA—uterine cancer	4.06e-05	0.000213	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CA—uterine cancer	4.06e-05	0.000213	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKT1—uterine cancer	3.32e-05	0.000174	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKT1—uterine cancer	3.32e-05	0.000174	CbGpPWpGaD
